Bioanalytical Community

 View Only
Back to discussions
Expand all | Collapse all

Immunogenicity Discussion Group: Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance

  • 1.  Immunogenicity Discussion Group: Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance

    Community Leadership
    Posted 11-21-2023 12:03

    Hi All,

    At the Immunogenicity Discussion Group (IDG) call on Wednesday December 6th (12:00 Eastern US, 18:00 Europe) we will have Xinyuan Li (Nemo) and the team from J&J take us through their recent AAPS Journal publication 'Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance'.

    If you and/or team members/colleagues would like to join the discussion, please let Todd Lester and myself know ([email protected], [email protected]) and we'll get you added to the invitation...

    Please also check out the thread for the IDG event on Monday December 11th.



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------


  • 2.  RE: Immunogenicity Discussion Group: Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance

    Community Leadership
    Posted 12-01-2023 09:25

    For those that may have missed it during the Thanksgiving break, a quick reminder to let Todd and I know if you'd like to join this AAPS Immunogenicity Discussion Group call.

    ---

    At the Immunogenicity Discussion Group (IDG) call on Wednesday December 6th (12:00 Eastern US, 18:00 Europe) we will have Xinyuan Li (Nemo) and the team from J&J take us through their recent AAPS Journal publication 'Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance'.



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------

    Original Message


  • 3.  RE: Immunogenicity Discussion Group: Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance

    Community Leadership
    Posted 12-07-2023 05:10

    Our thanks to Nemo for a really excellent presentation and Q&A at yesterday's AAPS IDG meeting on 'Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance'.

    We have posted the recording here, and will keep it available for a few weeks for anyone who wishes to see it on-demand. The recording can be viewed by anyone who has the link,  but is unlisted, so won't appear in any search results.



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------

    Original Message